The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
Health-Related Quality of Life Across the Anxiety Disorders: Results From the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC)
Open accessAbstract
OBJECTIVE: Although clinical studies have documented that specific anxiety disorders are associated with impaired psychosocial functioning, little is known regarding their comparative effects on health-related quality of life within a general population. The current analysis compares health-related quality of life in a US community-dwelling sample of adults with DSM-IV social anxiety disorder, generalized anxiety disorders (GAD), panic disorder, and specific phobia. METHOD: A face-to-face survey of a US nationally representative sample of over 43,000 adults aged 18 years and older residing in households and group quarters was conducted. Prevalence of DSM-IV anxiety disorders and relative associations with health-related quality of life indicators were examined. The survey was conducted from 2001 to 2002. RESULTS: Roughly 9.8% of respondents met diagnostic criteria for at least 1 of 4 twelve-month DSM-IV anxiety disorders which, relative to the non-anxiety-disordered general population, were each associated with lower personal income, increased rates of 12-month physical conditions, and greater numbers of Axis I and Axis II DSM-IV psychiatric conditions. After adjusting for sociodemographic and clinical correlates, including other anxiety disorders, GAD was associated with significant decrements in the SF-12 mental component summary score. In similar models, GAD and, to a lesser extent, panic disorder were significantly associated with impairment in social functioning, role emotional, and mental health SF subscales. CONCLUSIONS: GAD, followed by panic disorder, appears to exact significant and independent tolls on health-related quality of life. Results underscore the importance of prompt and accurate clinical identification and improving access to effective interventions for these disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Anxiety disorders are associated with high socioeconomic costs and often a chronic, debilitating course for the affected person [5–7].”
From Results of a randomized controlled superiority trial of the effect of modified collaborative assessment vs. standard assessment on patients’ readiness for psychotherapy (CO-ASSM-RCT) (2024) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Patients with anxiety disorders have a higher prevalence of hypertension and other cardiovascular conditions, gastrointestinal disease, arthritis, thyroid disease, respiratory disease, migraine headaches, and allergic conditions compared to those without anxiety disorders [16,52].”
From Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders (2014) · cites this paper as [16]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Medical conditions frequently reported in patients with anxiety and related disorders include cardiovascular disease, gastrointestinal disease, arthritis, respiratory disease, thyroid disease, migraine, and allergic conditions [16,52].”
From Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders (2014) · cites this paper as [16]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Medical conditions are reported in over 60% of patients with anxiety and related disorders including cardiovascular diseases, gastrointestinal diseases, arthritis, respiratory diseases such as asthma, thyroid disease, migraine headaches, back pain, and allergic conditions [16,52,1430-1432].”
From Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders (2014) · cites this paper as [16]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Comorbidities are particularly common among patients with GAD, panic disorder, and PTSD [16,140,515, 517,1390,1433].”
From Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders (2014) · cites this paper as [16]
Experimental — accuracy not yet measured
The cited source says what the claim attributes to it.
In the citing paper
“Anxiety and related disorders often present together with other psychiatric or medical conditions [3,16,43, 1382,1383].”
From Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders (2014) · cites this paper as [16]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Merikangas, K. R., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.593 · Cited by 20,391
Kessler, R. C., Chiu, W. T., Demler, O., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.617 · Cited by 12,052
SF-36 health survey: Manual and interpretation guide
Ware, J. (2003) · Medical Entomology and Zoology · Cited by 11,424
Equivalence of the Mediation, Confounding and Suppression Effect
MacKinnon, D. P., Krull, J. L., & Lockwood, C. M. (2000) · Prevention Science · doi:10.1023/a:1026595011371 · Cited by 4,188
(1994) · Medical Entomology and Zoology · Cited by 4,156
Hasin, D. S., Stinson, F. S., Ogburn, E., & Grant, B. F. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.7.830 · Cited by 2,908
Self-citationGrant, B. F., Stinson, F. S., Dawson, D. A., Chou, S. P., Dufour, M. C., Compton, W., Pickering, R. P., & Kaplan, K. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.8.807 · Cited by 2,889
Self-citationOverview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project
Ware, J. E., & Gandek, B. (1998) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(98)00081-x · Cited by 2,667
Prevalence of and Risk Factors for Lifetime Suicide Attempts in the National Comorbidity Survey
Kessler, R. C., Borges, G., & Walters, E. E. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.7.617 · Cited by 2,514
Wittchen, H.-U. (1994) · Journal of Psychiatric Research · doi:10.1016/0022-3956(94)90036-1 · Cited by 2,348
Research works printed but not linked: 4
- [3]Kessler RC Greenberg PE Davis K The economic burden of anxiety and stress disorders Neuropsychopharmacology: The fifth generation of progress 2002 The American College of Neuropsychopharmacology and Lippincott Williams & Wilkins Baltimore, MD
- [21]Ware JE Kosinski M Keller SK How to Score the SF-12 Physical and Mental Health Summary Scales 1995 The Health Institute, New England Medical Center Boston, MA Second edition
- [22]Turner-Bowker DM Bartley PJ Ware JE SF-36 Health Survey & SF Bibliography: Third Edition (1988–2000) 2002 QualityMetric Inc Lincoln, RI
- [54]Manocchia M Bayliss MS Connor J Keller SD Shiely J-C Tasai C SF-36 Health Survey Annotated Bibliography: Second Edition (1988–1996) 1998 The Health Assessment Lab Boston, MA
Cited by
Sorted by citations
Items 201–214 of 214
Moon, J., Kim, H.-J., Song, C. R., Pae, C., & Lee, S. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.12.001
Shi, L. (2025) · International Journal of Psychophysiology · doi:10.1016/j.ijpsycho.2025.112584
Céoara, B., Dosquet, M., Rico, M. S., Geoffroy, P. A., Blanco, C., Limosin, F., & Hoertel, N. (2025) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2025.06.036
Self-citationPowell, C. L. Y. M., Chiu, C. Y., Sun, X., & So, S. H.-W. (2024) · Figshare · doi:10.6084/m9.figshare.24934351
Sanchez-Garcia, M., Díaz, C., & la Rosa-Cáceres, A. D. (2024) · Figshare · doi:10.6084/m9.figshare.26322612
Comer, J. S., Pincus, D. B., Adrian, M. C., McCreary, G., Miller, L., Munarriz, T., Myers, K., Pierre-Louis, K. X., Platt, R. E., Ripley, M., et al. (2025) · JAACAP Open · doi:10.1016/j.jaacop.2025.12.003
Self-citationShi, L. (2025) · International Journal of Psychology · doi:10.1002/ijop.70161
Seçer, İ., Çi̇men, F., Bülbül, B., & Briegel, W. (2026) · Current Psychology · doi:10.1007/s12144-025-08900-x · Cited by 1
Cui, X., Han, Y., Yan, H., Shan, X., Li, H., Hu, M., Liu, F., Yuan, Y., Li, P., Lv, D., et al. (2026) · Psychiatry Research · doi:10.1016/j.psychres.2026.117119
Rewards and Reinforcement in the Treatment of Youth Internalizing Problems
Beech, A., Kamenetskiy, A., Pincus, D. B., & Comer, J. S. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-29009-1.00006-8
Self-citationLaane, S. A., Cook, L. G., Spence, J. S., & Chapman, S. B. (2026) · Frontiers in Psychology · doi:10.3389/fpsyg.2026.1826717
Saini, U., Wanders, R., Oldehinkel, A. J., Rosmalen, J. G. M., & van Loo, H. M. (2026) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2026.08.006
Ekici, F., Karaoğlan, G., Ergün, M. T., Atılgan, M. C., Guler, O., & Demir, L. S. (2026) · The International Journal of Psychiatry in Medicine · doi:10.1177/00912174261494407
Neves, V. V., Larbi, N. A. O. O., Acabchuk, R. L., Haygood, L. N., Rajasankar, V., Goldberg, S. B., Sun, S., Hoge, E. A., Brewer, J. A., Li, C., et al. (2026) · medRxiv · doi:10.64898/2026.10.21.26366048
Metadata
- Authors
- Comer, J. S., Blanco, C., Hasin, D. S., Liu, S.-M., Grant, B. F., Turner, J. B., & Olfson, M.
- Affiliations
- New York State Psychiatric Institute (US)
- National Institute on Alcohol Abuse and Alcoholism (US)
- Corresponding author
- Olfson, Mark
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2010-08-24
- Volume
- 72
- Issue
- 01
- Pages
- 43-50
- ISSN
- 0160-6689 (ISSN-L)
- PMC
- PMC3000882
- OpenAlex
- W2011237439
- Cited by
- 214
- References
- 77
- Citations by year
- 2026: 10 · 2025: 11 · 2024: 17 · 2023: 14 · 2022: 17 · 2021: 21 · 2020: 10 · 2019: 17 · 2018: 16 · 2017: 15 · 2016: 12 · 2015: 13 · 2014: 18 · 2013: 15 · 2012: 3
- FWCI
- 9.57
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- American Foundation for Suicide Prevention
- Eli Lilly and Company
- Pfizer
- AstraZeneca
- GlaxoSmithKline
- National Institutes of Health (Z99‐AA999999)
- Agency for Healthcare Research and Quality (U18HS016097)
- National Institute on Alcohol Abuse and Alcoholism (Z01AA000449, AA-014223, K05AA014223)
- National Institute of Mental Health (T32MH016434, MH076051, R01MH076051)
- National Institute on Drug Abuse (R01DA020783, DA019606, DA020783, DA023200, R01DA019606, K02DA023200)
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Keywords
- health-related quality of life, anxiety disorders, generalized anxiety disorder, panic disorder, social anxiety disorder, specific phobia, social functioning, mental health, physical health, psychiatric comorbidity, income, community-dwelling adults
- MeSH terms
- Adolescent, Adult, Alcoholism, Anxiety Disorders, Data Collection, Female, Health Status, Health Surveys, Humans, Male, Psychiatric Status Rating Scales, Quality of Life, Surveys and Questionnaires, United States, Prevalence, Diagnostic and Statistical Manual of Mental Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
